- Home
- RLAY vs AIOT Comparison
RLAY vs AIOT Comparison
Compare RLAY & AIOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AIOT
- Stock Information
- Founded
- RLAY 2015
- AIOT 1993
- Country
- RLAY United States
- AIOT United States
- Employees
- RLAY N/A
- AIOT N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AIOT Telecommunications Equipment
- Sector
- RLAY Health Care
- AIOT Telecommunications
- Exchange
- RLAY Nasdaq
- AIOT Nasdaq
- Market Cap
- RLAY 576.1M
- AIOT 594.8M
- IPO Year
- RLAY 2020
- AIOT N/A
- Fundamental
- Price
- RLAY $3.63
- AIOT $4.45
- Analyst Decision
- RLAY Strong Buy
- AIOT Strong Buy
- Analyst Count
- RLAY 11
- AIOT 4
- Target Price
- RLAY $18.40
- AIOT $10.50
- AVG Volume (30 Days)
- RLAY 1.6M
- AIOT 2.3M
- Earning Date
- RLAY 08-05-2025
- AIOT 08-07-2025
- Dividend Yield
- RLAY N/A
- AIOT N/A
- EPS Growth
- RLAY N/A
- AIOT N/A
- EPS
- RLAY N/A
- AIOT N/A
- Revenue
- RLAY $7,679,000.00
- AIOT $362,515,000.00
- Revenue This Year
- RLAY $14.31
- AIOT $21.96
- Revenue Next Year
- RLAY N/A
- AIOT $10.74
- P/E Ratio
- RLAY N/A
- AIOT N/A
- Revenue Growth
- RLAY N/A
- AIOT 169.28
- 52 Week Low
- RLAY $1.78
- AIOT $3.70
- 52 Week High
- RLAY $10.72
- AIOT $8.71
- Technical
- Relative Strength Index (RSI)
- RLAY 63.22
- AIOT 40.53
- Support Level
- RLAY $3.10
- AIOT $4.22
- Resistance Level
- RLAY $3.75
- AIOT $4.59
- Average True Range (ATR)
- RLAY 0.23
- AIOT 0.23
- MACD
- RLAY 0.03
- AIOT -0.01
- Stochastic Oscillator
- RLAY 84.42
- AIOT 14.12
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.